BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30008448)

  • 1. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
    J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
    Bass RD; Moore DF; Steen VD
    Arthritis Care Res (Hoboken); 2024 Mar; 76(3):311-317. PubMed ID: 37691427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
    Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
    Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
    Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
    Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
    Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
    Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments.
    Scherlinger M; Lutz J; Galli G; Richez C; Gottenberg JE; Sibilia J; Arnaud L; Blanco P; Schaeverbeke T; Chatelus E; Truchetet ME
    Semin Arthritis Rheum; 2021 Feb; 51(1):36-42. PubMed ID: 33360228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
    Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
    Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Survival of Systemic Sclerosis-Sarcoidosis Overlap Syndrome.
    Himmel M; Balter M; Ahmad Z; Bangert E; Hasmani S; Siddha R; Movahedi M; Johnson SR
    J Rheumatol; 2023 May; 50(5):656-661. PubMed ID: 36725057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
    Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
    Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary hypertension in autoimmune rheumatic diseases].
    Marasini B; Massarotti M; Cossutta R; Massironi L; Mantero A
    Reumatismo; 2005; 57(2):114-8. PubMed ID: 15983635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
    Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
    Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
    Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
    Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.